Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells

Blood

Volumn 94, Issue 8, 1999, Pages 2862-2870

  Mori, Naoki ^a   Nunokawa, Youichi ^b   Yamada, Yasuaki ^b   Ikeda, Shuichi ^b   Tomonaga, Masao ^b   Yamamoto, Naoki ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE;

ARTICLE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0032833974     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.8.2862.420k24_2862_2870     Document Type: Article

References (44)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415, 1980
2. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031, 1982
3. Gassain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407, 1985
4. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031, 1986
5. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M: Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1:441, 1989
6. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N: HTLV-I uveitis: A distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83:236, 1992
7. Ishii K, Yamato K, Iwahara Y, Eguchi T, Uemura Y, Takehara N, Ohtsuki Y, Taguchi H, Miyoshi I: Isolation of HTLV-I from muscle of a patient with polymyositis. Am J Med 90:267, 1991
8. Vernant J-C, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vemant C, Monplaisir N: T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome. Lancet 1:177, 1988
9. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051, 1992
10. Nathan C, Xie Q-W: Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725, 1994
11. Nathan C, Xie Q-W: Nitric oxide synthases: Roles, tolls, and controls. Cell 78:915, 1994
12. Denis, M: Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacferium avium and to kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 49:380, 1991
13. Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC: Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 99:110, 1997
14. Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J, Simmons RL: Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176:261, 1992
15. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM: Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 71:1088, 1992
16. Lelchuk R, Radomski MW, Martin JF, Moncada S: Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. J Pharmacol Exp Ther 262:1220, 1992
17. Charles IG, Palmer RM, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S: Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 90:11419, 1993
18. Arany I, Brysk MM, Brysk H, Tyring SK: Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes. Biochem Biophys Res Commun 220:618, 1996
19. Sherman PA, Laubach VE, Reep BR, Wood ER: Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 32:11600, 1993
20. Nunokawa Y, Oikawa S, Tanaka S: Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-κB dependent mechanism. Biochem Biophys Res Commun 223:347, 1996
21. Franchini G: Molecular mechanisms of human T-cell leukemia/ lymphotropic virus type I infection. Blood 86:3619, 1995
22. Ohtani K, Tsujimoto A, Tsukahara T, Numata N, Miura S, Sugamura K, Nakamura M: Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I. J Biol Chem 273:14119, 1998
23. Tanaka Y, Yoshida A, Takayama Y, Tsujimoto H, Tsujimoto A, Hayami M, Tozawa H: Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses. Jpn J Cancer Res 81:225, 1990
24. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka, M: Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 87:1071, 1990
25. Matsumoto K, Shibata H, Fujisawa J, Inoue H, Hakura A, Tsukahara T, Fujii M: Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J Virol 71:4445, 1997
26. Ruben SM, Narayanan R, Klement JF, Chen C-H, Rosen CA: Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative. Mol Cell Biol 12:444, 1992
27. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW: Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol 15:2809, 1995
28. McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL, Ballard DW: Inactivation of I κBβ by the Tax protein of human T-cell leukemia virus type 1: A potential mechanism for constitutive induction of NF-κB. Mol Cell Biol 16:2083, 1996
29. Mon N, Prager D: Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 87:3410, 1996
30. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS: Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137, 1994
31. Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, Kolb J-P: B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood 92:1031, 1998
32. Goto H, Nakamura T, Shirabe S, Ueki Y, Nishiura Y, Furuya T, Tsujino A, Nakane S, Eguchi K, Nagataki S: Up-regulation of iNOS mRNA expression and increased production of NO in human monoblast cell line, U937 transfected by HTLV-I Tax gene. Immunobiol 197:513, 1997
33. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ: Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc Natl Acad Sci USA 90:9730, 1993
34. Xie QW, Whisnant R, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J Exp Med 177:1779, 1993
35. Xie QW, Kashiwabara Y, Nathan C: Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705, 1994
36. Martin E, Nathan C, Xie QW: Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180:977, 1994
37. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TR, Hutchinson NI, Mudgett JS: Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269:6765, 1994
38. Nunokawa Y, Ishida N, Tanaka S: Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem Biophys Res Commun 200:802, 1994
39. de Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM Jr, Billiar TR, Geller DA: Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 93:1054, 1996
40. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM Jr, Billiar TR, Geller DA: Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273:15148, 1998
41. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, Nishioka K, Yamamoto K, Takeda T, Hatanaka M, Yamamoto H, Sekiguchi T: Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253:1026, 1991
42. Evans CH, Stefanovic-Racic M, Lancaster J: Nitric oxide and its role in orthopaedic disease. Clin Orthop Rel Res 312:275, 1995
43. Farrell AJ, Blake DR, Palmer RM, Moncada S: Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219, 1992
44. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N: Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96:2357, 1995